Review





Similar Products

93
Sino Biological f2 acaggagtgcatagtgagctcgatctgacccagac r2 ggtgcaactggatcccctttgacgaccacctcggt 1 4 function analysis
F2 Acaggagtgcatagtgagctcgatctgacccagac R2 Ggtgcaactggatcccctttgacgaccacctcggt 1 4 Function Analysis, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/f2 acaggagtgcatagtgagctcgatctgacccagac r2 ggtgcaactggatcccctttgacgaccacctcggt 1 4 function analysis/product/Sino Biological
Average 93 stars, based on 1 article reviews
f2 acaggagtgcatagtgagctcgatctgacccagac r2 ggtgcaactggatcccctttgacgaccacctcggt 1 4 function analysis - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

94
Novus Biologicals polyclonal rabbit anti coagulation factor ii thrombin antibody
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
Polyclonal Rabbit Anti Coagulation Factor Ii Thrombin Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti coagulation factor ii thrombin antibody/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
polyclonal rabbit anti coagulation factor ii thrombin antibody - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Aniara Inc an anti-prothrombin antibody (cl20110a)
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
An Anti Prothrombin Antibody (Cl20110a), supplied by Aniara Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an anti-prothrombin antibody (cl20110a)/product/Aniara Inc
Average 90 stars, based on 1 article reviews
an anti-prothrombin antibody (cl20110a) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Boster Bio emp1
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
Emp1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/emp1/product/Boster Bio
Average 92 stars, based on 1 article reviews
emp1 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc anti transcription factor ii b
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
Anti Transcription Factor Ii B, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti transcription factor ii b/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
anti transcription factor ii b - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

94
Novus Biologicals rabbit anti thrombin
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
Rabbit Anti Thrombin, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti thrombin/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
rabbit anti thrombin - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

86
Danaher Inc mouse monoclonal anti prothrombin antibody
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
Mouse Monoclonal Anti Prothrombin Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti prothrombin antibody/product/Danaher Inc
Average 86 stars, based on 1 article reviews
mouse monoclonal anti prothrombin antibody - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
Inova Diagnostics anti-phosphatidylserine/prothrombin igg
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
Anti Phosphatidylserine/Prothrombin Igg, supplied by Inova Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-phosphatidylserine/prothrombin igg/product/Inova Diagnostics
Average 90 stars, based on 1 article reviews
anti-phosphatidylserine/prothrombin igg - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Merck & Co anti-prothrombin [factor ii (fii)] mouse monoclonal igg
(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit <t>polyclonal</t> ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.
Anti Prothrombin [Factor Ii (Fii)] Mouse Monoclonal Igg, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-prothrombin [factor ii (fii)] mouse monoclonal igg/product/Merck & Co
Average 90 stars, based on 1 article reviews
anti-prothrombin [factor ii (fii)] mouse monoclonal igg - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Inova Diagnostics anti-phosphatidylserine/prothrombin antibody (aps/pt) igg/igm
Prevalence of aPL in COVID-19 patients with and without thrombosis.
Anti Phosphatidylserine/Prothrombin Antibody (Aps/Pt) Igg/Igm, supplied by Inova Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-phosphatidylserine/prothrombin antibody (aps/pt) igg/igm/product/Inova Diagnostics
Average 90 stars, based on 1 article reviews
anti-phosphatidylserine/prothrombin antibody (aps/pt) igg/igm - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


(A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit polyclonal ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.

Journal: bioRxiv

Article Title: Targeting Iron - Respiratory Reciprocity Promotes Bacterial Death

doi: 10.1101/2024.03.01.582947

Figure Lengend Snippet: (A) N-104 killing assay of PA14 at 300 mOsm/l. (B) N-104 column capture of thrombin from pooled human basal tears, as per absence in the final wash fraction and detection in the KCl elution fractions. None bound to the negative control C-95 column. (C) GKY20 solution killing assay of PA14. Optimization of GKY20 concentration for checkerboard assay with N-104. (D) Replicates of N-104 checkerboard assays with GKY20 or each with peptides of gelsolin and cystatin S. (E) N-104, but not C-95, binding of immobilized thrombin peptide GKY20 as respectively detected with rabbit polyclonal ab-C-term or ab-N-term anti-lacritin antibodies. (F) N-104 and N-104 analog ligation of immobilized thrombin peptide GKY20 as detected with rabbit polyclonal ab-C-term anti-lacritin antibodies. (G) Ab-C-term antibody detects N-104 but not N-104 ‘L108S/L109S/F112S/L114S/L115S/W118S’ (’LFW:S’). (H) Since ab-C-term antibody cannot detect N-104 LFW:S, the capacity of increasing amounts of LFW:S to inhibit N-104 ligation of GKY20 was assessed. (I) N-104 versus LFW:S killing assay of PA14.

Article Snippet: Anti-thrombin western blotting of non-boiled flowthrough, final wash fraction and KCl elution fractions in 4x Laemmli buffer containing 10% β-mercaptoethanol was performed after separation on 4 - 20% gradient SDS-PAGE gels (4561094, Bio-Rad), transfer onto nitrocellulose (10600001, GE Healthcare Life Sciences), blocking with 1% fish gelatin (G7765, Sigma) in 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 2.7 mM KCl, 137 mM NaCl, pH 7.2 supplemented with 0.1% Tween-20 (1706531, Bio-Rad), and then incubation overnight (4°C) with 10 ml of 1 μg/ml of polyclonal rabbit anti-coagulation factor II/thrombin antibody (NBP1-58268, Novus Biologicals; antigen comprises amino acids 395 - 445) in 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 2.7 mM KCl, 137 mM NaCl, pH 7.2 supplemented with 0.1% Tween-20 (1706531, Bio-Rad) and 0.05% sodium azide.

Techniques: Negative Control, Concentration Assay, Binding Assay, Ligation

Prevalence of aPL in COVID-19 patients with and without thrombosis.

Journal: Frontiers in Immunology

Article Title: Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching

doi: 10.3389/fimmu.2023.1227547

Figure Lengend Snippet: Prevalence of aPL in COVID-19 patients with and without thrombosis.

Article Snippet: The non-criteria aPL, anti-phosphatidylserine/prothrombin antibody (aPS/PT) IgG/IgM (INOVA Diagnostics) and aβ2GPI IgA (IBL international GmbH), were analyzed by enzyme-linked immunosorbent assay (ELISA).

Techniques: Significance Assay